Cite
HARVARD Citation
Facchinetti, F. et al. (2018). Meeting with triumph and disaster: Osimertinib in T790M-unknown CNS progression in EGFR-mutated non-small cell lung cancer. Tumori. 104 (6), pp. NP29-NP33. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Facchinetti, F. et al. (2018). Meeting with triumph and disaster: Osimertinib in T790M-unknown CNS progression in EGFR-mutated non-small cell lung cancer. Tumori. 104 (6), pp. NP29-NP33. [Online].